<DOC>
	<DOC>NCT00562549</DOC>
	<brief_summary>The purpose is to determine the effective dosage and to study the effects of this dosage taken for 12 days on systolic and diastolic blood pressure in patients with hypertension.</brief_summary>
	<brief_title>Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension</brief_title>
	<detailed_description>1. Office seated peripheral systolic and diastolic blood pressure 2. Adverse events and vital signs 3. Plasma concentrations of SLx-2101</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male or females between 18 and 80 years, inclusive Moderate to severe hypertension Body weight within a body mass index range of 18 32 kg/m2 Subject is receiving more than four antihypertensive agents History of drug abuse Exposure to a new chemical entity within 3 months prior to the first day of dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>